These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9072434)
1. Hypotensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously and renal hypertensive rats. Ishii R; Naruse T; Tagawa T; Ishida T; Namba K Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S374-6. PubMed ID: 9072434 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats. Ishii R; Tagawa T; Ishida T; Naruse T Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats. Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013 [TBL] [Abstract][Full Text] [Related]
4. Preclinical assessment of a new transdermal delivery system for clonidine (M-5041T). Naruse T; Ishida T; Ishii R; Tagawa T Fundam Clin Pharmacol; 1996; 10(1):47-55. PubMed ID: 8900500 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs. Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815 [TBL] [Abstract][Full Text] [Related]
6. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs. Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats. Takada T; Miyawaki N; Kageyama M; Matsuno K; Ishida N; Yamauchi H; Iso T J Cardiovasc Pharmacol; 1991 Dec; 18(6):855-62. PubMed ID: 1725898 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models. Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746 [TBL] [Abstract][Full Text] [Related]
9. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL; Turgeon A; Deng LY Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550 [TBL] [Abstract][Full Text] [Related]
10. [Antihypertensive effect of felodipine, a new calcium antagonist]. Inoue T; Omosu M; Hayashi S; Sakaguchi S; Nakao K; Inukai T; Odagiri N; Ono T Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):453-62. PubMed ID: 1464403 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats. Morita T; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824 [TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models]. Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the long-lasting antihypertensive action of 7-O-ethylfangchinoline. Kato T; Noguchi K; Sakanashi M Jpn J Pharmacol; 1994 Sep; 66(1):35-46. PubMed ID: 7861666 [TBL] [Abstract][Full Text] [Related]
14. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline. Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126 [TBL] [Abstract][Full Text] [Related]
15. Absence of tolerance to hypotensive effects of clonidine in spontaneously hypertensive rats. Naruse T; Ishii R; Tagawa T Jpn J Pharmacol; 1995 Apr; 67(4):407-410. PubMed ID: 7650877 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats. Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of a novel calcium antagonist, semotiadil fumarate (SD-3211), alone and in combination with enalapril or trichlormethiazide in spontaneously hypertensive rats. Ichikawa M; Wanaka M; Ohtsuji T; Akashi S; Machidera Y; Manno K; Nakamuta H; Koida M Biol Pharm Bull; 1994 Nov; 17(11):1513-5. PubMed ID: 7703975 [TBL] [Abstract][Full Text] [Related]
19. Effects of a newly developed transdermal clonidine delivery system (M-5041T) on EEG sleep-wake cycle in relation to plasma concentration in rabbits. Kimura K; Ishihara K; Tagawa T; Sakurai M; Fujii Y; Dote S; Naruse T; Sasa M; Namba K Gen Pharmacol; 1996 Jan; 27(1):73-7. PubMed ID: 8742497 [TBL] [Abstract][Full Text] [Related]
20. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Armah BI; Hofferber E; Stenzel W Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]